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ABSTRACT
Background: Recently, extensive research has established that epidemiologic and therapeutic links exist be-
tween allergic rhinitis and asthma. The objective of this study was to clarify this association in Iraq.
Methods: The data included in this study were collected from five surveys for asthma and allergic rhinitis that
were performed during the period from September 2000 to July 2008. These surveys were parts of Tikrit Uni-
versity College of Medicine PHC program.
Results: The frequency of allergic rhinitis (AR) was 61.6% among individuals with asthma versus 6% among
non-asthmatic (control) subjects (Odd Ratio [OR] = 25.5; P < 0.0001). All studies indicated a significant fre-
quency of AR among asthmatic patients in comparison with non-asthmatic subjects, whether the patients were
adults or children (OR for adults = 14.9 and 22.5, for children 34.7 and 48.4; P < 0.001 for all). Furthermore, the
high frequency of AR in asthmatic patients was seen whether the study was a community based study (CBS)
(OR = 14.9 and 48.4; P < 0.0001) or a hospital based study (HBS) (OR = 22.5 & 34.7; P < 0.0001). The fre-
quency of current asthma was 51.8% among individuals with AR versus 5.4% among control subjects (OR =
23.1; P < 0.0001).
Conclusions: This study provided evidence that AR and asthma are strongly associated with each other and
the treatment approach should consider the entire airway rather than only a part.
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INTRODUCTION
Asthma is one of the most common chronic diseases
worldwide.1 A large percentage of children and adults
with asthma also have allergic rhinitis (AR).2 The link
between AR and asthma has long been of interest to
physicians. Recently, extensive research has estab-
lished that epidemiologic and therapeutic links exist
between AR and asthma.3 A number of epidemiologic
studies have shown an association between asthma
and allergic rhinitis. In a review of five large studies
that included populations of children and adults,4 the
prevalence of asthma ranged from 3.6% to 5% in sub-
ject without rhinitis versus 10.8% to 32% in subject
with rhinitis. In a 23 year follow-up study in university
students,5 asthma developed in 10.5% of subjects with
AR, whereas it developed in only 3.6% of subjects
without AR. In addition, the reported lifetime preva-
lence of AR among adults with asthma ranges from
50% to 100%, varying by study design and geographi-
cal areas.6
Asthma and AR are both inflammatory diseases of
the airways. The similarities between AR and asthma
in epidemiologic and pathophysiologic features sug-
gest that AR and asthma represent the same syn-
drome, the chronic allergic respiratory syndrome.7 A
report of the American Academy of Allergy, Asthma,
and Immunology8 estimated that up to 78% of patients
with asthma have nasal symptoms and 38% of patients
with AR have asthma. While there are several sur-
veys assessing the association between AR and
asthma in different geographical areas worldwide,
none were performed in large scale studies. Thus,
this studywas performed to clarify this association in Iraq.
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Table 1 Study population
Number examinedTypeAgeResidenceStudy
1384Community based studyAdultRural1
8687Hospital based studyAdultUrban2
3780Hospital based studyChildren
2875Community based studyChildrenUrban3
9317Hospital based studyMixedUrban & rural4
8747Hospital based studyMixedUrban & rural5
METHODS
STUDY POPULATION
The data included in this study was collected from
five surveys for asthma and allergic rhinitis that were
performed during the period from September 2000 to
July 2008. These surveys were part of Tikrit Univer-
sity College of Medicine PHC program. (Table 1).
The first survey was a community-based study that
was performed in Al-Hjaj village (rural area) to deter-
mine the prevalence of bronchial asthma in adults.
1384 individuals were included in this cross-sectional
study. This number represents all adults of the vil-
lage. The village was located 40 miles from Tikrit city.
This study was carried out during the period from
September 18, 2002 to December 3, 2002. The age
range of the study population was from 18 to 45 years
and 760 (54.9%) were men and 624 (45.1%) were
women.
The second survey was a hospital-based study that
included a mixed population from urban and rural ar-
eas. This included the patients attending the Tikrit Al-
lergy and Asthma Centre during the period from Sep-
tember 2000 to July 2008. 12467 patients were in-
cluded in the study, of them 8687 (69.7%) were adults,
and 3780 (30.3%) were children.
The third survey was a community-based study
that included primary school children in Samara city
(urban area). The children were all preadolescent
school age children. The total number of primary
school children in Samara city was 10820 children,
5397 boys and 5423 girls. We chose 2875 children in
grade 5 and 6, 1624 (56.5%) boys and 1251 (43.5%)
girls. These two grades were selected because these
grades performed the exercise challenge and peak
flow metric measures better than younger age groups
and the questionnaire data obtained from them were
more accurate.
The fourth survey was a hospital-based study per-
formed at Tikrit Teaching Hospital to determine the
epidemiological characteristic of allergic rhinitis. The
study population was a mixture of rural and urban in-
habitants. A total number of 9317 individuals were in-
cluded in the study, of them 5198 (55.8 %) were men
and 4119 (44.2 %) were women.
The fifth survey was a hospital-based study per-
formed in Samara General Hospital during the period
from September 2000 to July 2008 to determine the
epidemiological characteristics of AR in Samara. The
population was a mixture of rural and urban individu-
als both men and women. A total of 8748 patients
were included in the analysis, of them 5608 (64.1 %)
were men and 3140 (35.9 %) were women.
Eosinophil cationic protein (ECP, as a marker of
eosinophil), malondialdehyde (MDA) and total anti-
oxidant capacity (TAC) (as markers of oxidative
stress) were determined in 100 patients with AR
alone100 patients with asthma alone100 patients
with AR and asthma together and in 50 healthy con-
trols.
ASTHMA AND ALLERGIC RHINITIS DIAGNOSIS
The diagnosis of asthma and classification was per-
formed by specialist physicians based on the National
Heart Blood and Lung InstituteWorld Health Or-
ganization (NHLBIWHO) workshop on the Global
Strategy for Asthma.9 Allergic rhinitis diagnosis was
performed according to previously reported guide-
lines.10 Patients were excluded if they were smokers,
if they had respiratory infection within the month pre-
ceding the study, a rheumatological illness, malig-
nancy, diabetes, heart failure, history of venous em-
bolisms, coronary heart disease and liver or kidney
diseases. At enrollment, they all underwent a full
clinical examination, pulmonary function test, and
blood sampling.
DETERMINATION OF TOTAL ANTIOXIDANT CA-
PACITY
The method for serum TAC determination as previ-
ously described by Kampa M et al.11 was used.
DETERMINATION OF MALONDIALDEHYDE
Serum MDA concentration was determined by meas-
uring the thiobarbituric acid reactive substances
(TBARS) according to the spectrophotometric
method of Janero.12 The TBARS was determined us-
ing OXITEK TBARS Assay kit from Zeptometrix Cor-
poration (Buffalo, NY, USA).
DETERMINATION OF OXIDATION INDEX
The index was determined by the following equation.
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Table 2 Frequency distribution of alergic rhinitis in asthmatic patients and non-asthmatic patients
OR
Frequency of alergic rhinitis
AgeStudy Non-asthmatic patientsAsthmatic patients
%ARNo.%ARNo.
14.910.1129128062.9 65 104Adult1
22.5 3.8294 766147.34901036Adult
2
34.7 1.2 42 347229.5 91 308Children
48.4 5.8153 261974.9192 256Children3
16.9 7.2423 894170.35551140Adult
Total 30.5 5.1195 609156.9283 564Children
25.5 6.06181503261.68381604Al
Mean value of MDA
Mean value of TAC 
×1000
DETERMINATION OF SERUM EOSINOPHILS
CATIONIC PROTEIN
Serum ECP was determined by ELISA kit (MBL
MESCACUP ECP TEST) from Medical and Biologi-
cal Laboratories Co, LTD, Nagoya, Japan.
STATISTICAL ANALYSIS
Data concerning the comparisons among the various
parameters in the study groups are given as mean
(SD) with 95% confidence intervals for the differ-
ences. Student’s unpaired one tailed test was used for
significant testing.
RESULTS
Information for 1704 (1140 adults and 564 children)
subjects with asthma and 15032 non-asthmatic (con-
trol) subjects were analyzed concerning the presence
of allergic rhinitis in asthmatic patients (Table 2). The
frequency of allergic rhinitis (AR) was 61.6% among
individuals with asthma versus 6% among non-
asthmatic (control) subjects (OR = 25.5; P < 0.0001).
When the analysis was performed after classification
of asthmatic patients into adults and children there
was still a positive association between frequency of
AR and asthma (P < 0.0001). For adults the frequency
of AR was 70.3% among adults with asthma versus
7.2% among non-asthmatic adults, (OR = 16.9; P <
0.0001), while in children the frequency of AR among
asthmatic patients was 56.9% versus 5.1% among non-
asthmatic children (OR = 30.5; P < 0.0001) as shown
in Table 2. All studies indicated a significant fre-
quency of AR among asthmatic patients in compari-
son with non-asthmatic subjects, whether the patients
were adults or children (OR for adults = 14.9 and
22.5, for children 34.7 and 48.4; P < 0.001 for all). Fur-
thermore, the high frequency of AR in asthmatic pa-
tients was seen whether the study was CBS (OR =
14.9 and 48.4; P < 0.0001) or HBS (OR = 22.5 and
34.7; P < 0.0001).
The information for 1682 subjects with AR and
28849 non-allergic rhinitis individuals (control) was
analyzed concerning the presence of asthma in pa-
tients with AR (Table 3). The frequency of current
asthma was 51.8% among individuals with AR versus
5.4% among control subjects (OR = 23.1; P < 0.0001).
When data of AR was evaluated for each survey
alone, frequencies were of 32.8%, 42.5%, and 63.4% for
asthma among individuals with AR in surveys 4, 5 and
2 respectively. These frequencies were significantly
higher (OR = 11, 13.8, and 24.4; P < 0.0001) than
those of individuals without AR (Table 3). Further-
more, the differences in frequency of asthma among
AR individuals were significantly higher (P < 0.0001),
whether the patients were adults (62.5%; OR = 22.5)
or children (68.4%; OR = 34.2).
Comparison of mean serum level of ECP, MDA,
and TAC in patients with AR alone, asthma alone and
presence of both conditions in the same group indi-
cated differences in their values between groups (Ta-
ble 4). The mean serum level of ECP was signifi-
cantly higher in the three groups as compared to con-
trol (P < 0.0001). However, there were significant dif-
ferences (P < 0.0001) in the mean serum ECP values
between the AR alone group (14.85 ± 8.23 μgl, Confi-
dence Interval 13.25-16.45 μgl), the asthma alone
group (36.12 ± 12.76 μgl, Confidence Interval 32.6-
39.6 μgl) and the group of patients with both AR and
asthma together (58.21 ± 13.6 μgl, Confidence Inter-
val 55.5-60.9). Concerning MDA there was a signifi-
cant increase in serum level mean values between the
three groups and the control (P < 0.0001). In addition,
patients with both AR and asthma (7.23 ± 2.82 μmoll,
Confidence Interval 6.6-7.8) had a mean value of se-
rum MDA significantly (P < 0.0001) higher than that
in patients with AR alone (3.49 ± 1.84 μmoll, Confi-
dence Interval 3.1-3.9) or patients with asthma alone
(4.41 ± 1.9 μmoll, Confidence Interval 4.04-4.78).
However, the difference between mean serum MDA
values in patients with asthma alone (4.41 μmoll)
and patients with AR alone (3.49 μmoll) was not sig-
nificant. TAC shows a lower level of mean value in pa-
tients with AR and asthma (771 ± 162 μmoll, CI 739-
803) as compared to patients with asthma alone
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Table 3 Frequency distribution of asthma in patients with and without alergic rhinitis
OR
Asthma
AgeStudy Non-AR patientsAlergic rhinitis patients
%AsthmaNo.%AsthmaNo.
11  4.2 381 895432.8119 363Mixed4
13.85.1 426 834542.5171 402Mixed5
24.46.6 7631155063.4581 917Mixed2
23.15.415702884951.88711682Total
Table 4 Serum eosinophilic cationic protein, MDA, TAC and oxidation index in patients with AR and asthma
Oxidation IndexTAC μmol/lMDA μmol/lECPμg/lGroup 
4.9 897 ± 178
(862-932)
4.41 ± 1.9 
(4.04-4.78)
36.12 ± 12.76
(32.64-39.6)
Patients with
asthma alone
3.5 986 ± 112
(964-1008)
3.49 ± 1.84
(3.13-3.85)
14.85 ± 8.23 
(13.25-16.45)
Patients with
AR alone
9.4 771 ± 162
(739-803)
7.23 ± 2.82
(6.63-7.83)
58.21 ± 13.6 
(55.54-60.88)
Patients with
AR and asthma
2.11047 ± 207
(1015-1133)
2.24 ± 0.26
(2.16-2.30)
7.68 ± 5.63
(6.08-9.68)
Control 
(897 ± 178 μmoll, CI 862-932) and patients with AR
alone (987 ± 112 μmoll, CI 964-1008). However, all
three groups had significantly (P < 0.1 to 0.001) lower
serum values as compared to the control group. The
oxidation index was 4 times higher in patients with
AR and asthma together than in the control group
(2.1), 1.5 times than in patients with AR alone (3.5)
and 2 times than in patients with asthma alone (4.9).
DISCUSSION
The results from our analysis of a large cohort con-
sisting of two community-based and hospital-based
studies show that there was a relationship between
asthma and allergic rhinitis (OR = 11-48.4). The rela-
tionship was seen whether the analysis was per-
formed for each survey alone or when the patients
were classified into adults and children, or when the
five surveys were combined together. The present
study showed a prevalence rate of 61.6% of AR in asth-
matic patients and there was a significant difference
in prevalence rate whether the patients were adults
or children or the survey was community-based or
hospital-based as compared to subjects without
asthma. This result is consistent with the percentage
reported for other geographical areas.6
Allergic rhinitis is very common in patients with
asthma,13 with a reported prevalence of up to 100% in
those with allergic asthma.14 In a recent review,6 the
point prevalence of AR ranged from 24% to 94% and
lifetime prevalence ranged from 50% to 100% among
adults with asthma in Europe and in the United
States. These findings have been corroborated in
more recent studies from Europe and Japan.15,16 In
this study the prevalence rate of AR was 70.3% among
adults, 56.9% among children and 61.6% among total
patients with asthma. The variability in the reported
prevalence of comorbid AR in patients with asthma in
the reported studies was attributable in part to differ-
ences in diagnostic criteria, study design6 and per-
haps geographical variations due to influence of air
pollution.
Geographical differences may exist also.17 One
study from China reported a lower (6%) prevalence of
comorbid AR in people with asthma.18 Among school
age children surveyed in the international study of
asthma and allergy in children, there are striking
variations in the prevalence of asthma and allergic
rhinoconjunctivitis symptoms recorded among differ-
ent centers worldwide17; nonetheless, significant cor-
relations are noted between the prevalence of asthma
and allergic rhinoconjunctivitis symptoms.19,20
Several reported studies have examined the asso-
ciation between AR and asthma. In the Rochester,
Minnesota, USA study,21 the overall prevalence of AR
was 52% among their study population. In the UK,
Medline-plus general practice databased studies22,23;
concomitant AR was documented in medical records
of only 17% of adult patients and in 20% of children
with asthma. Similarly in Norway, AR was docu-
mented in 27% of asthmatic children.24 Recently a
study25 of survey results from four countries each in
the Asia-Pacific region and Europe documented that
most patients (73%) had pre-existing symptoms of AR
when their asthma was first diagnosed.
It is possible that the prevalence of comorbid AR
among patients with asthma in these retrospective
studies was underestimated because the diagnosis of
AR was restricted to that recorded in medical re-
Allergic Rhinitis and Asthma
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cords,17 with the exception of that reported by
Valovirta,25 in which the adult patients and parents of
children filled a formulated questionnaire which is a
potential limitation.
In this study, the team members examined the re-
cruited subjects by surveys (1, 2, and 3) during the
study periods and thus the prevalence of comorbid
AR may be not underestimated. The possibility that
in part may lead to underestimation of AR prevalence
in patients with asthma was that many people with AR
self manage the condition with over the counter prod-
ucts, and do not seek a physician’s help or indeed do
not recognize AR as a condition needing treatment.15
There was a significantly higher frequency of AR in
asthmatic children in survey 3 (74.9%) compared to
survey 2 (29.5%). This variation may be due to the dif-
ference in the study design, since survey 2 was a
hospital-based study and while the survey 3 was a
community-based study. Concerning epidemiological
studies, the community-based studies are more ac-
cepted since the individuals in the selected sites are
examined.
Asthma is often present in patients with AR.17 The
present study documented a prevalence rate of 51.8%
of asthma in patients with allergic rhinitis versus 5.4%
in non-AR subjects (OR = 23.1). Linneburg et al.14 re-
ported asthma in 25% of patients with AR who were
pollen sensitive and in 50% of those AR patients who
were mite-sensitive or animal sensitive. Greisner et
al26 reported a history of asthma among 21% of for-
mer college students with a cumulative history of AR
over 23 years of follow-up. In the European Commu-
nity Respiratory Health survey, an association be-
tween asthma and rhinitis was observed even in non-
atopic individuals.27 This finding implies that the rela-
tionship cannot be fully explained by shared risk fac-
tors and supports the hypothesis that upper-airway
disorders may directly affect the lower airway.17 How-
ever, the reported studies combined indicate that AR
is a risk factor for the development of asthma.5,28-33
Bronchial hyper-responsiveness is common in peo-
ple with AR, even if they have no asthma symptoms
and asymptomatic airway hyper-responsiveness is as-
sociated with increased risk for developing
asthma.34-36 Bronchial inflammation can result from
nasal allergen challenge in patients with AR in the ab-
sence of obvious asthma.37 Conversely, patients with
asthma can have eosinophilic infiltration of their nasal
mucosa without reporting the symptoms of rhini-
tis.38,39
Bronchial asthma and AR are both chronic inflam-
matory diseases of the upper and lower airway, and
the cells mainly responsible for causing this inflam-
mation are eosinophils.40 Therefore, assessment of
serum ECP may be determined to reflect pulmonary
inflammation.41 Studies of asthmatic patients, espe-
cially adults, indicated a relationship between the se-
rum ECP level and severity and nature of the dis-
ease.42-45 The present study showed that mean serum
ECP levels were higher in subjects with asthma
alone, AR alone, or both asthma and AR compared to
controls.
This study indicates the role of eosinophilic inflam-
mation in asthma and allergic rhinitis suggesting a
significant impact on the management of AR and
asthma with anti-inflammatory medication increas-
ingly being recommended as first line therapy. It is
clear that our results are consistent with the previous
studies that reported a high serum ECP in asthmatic
patients41,46-48 and AR49,50 when compared with
healthy subjects. Serum mean ECP value was signifi-
cantly higher in patients with the two conditions (AR
and asthma) and patients with asthma alone as com-
pared with patients with AR alone, possibly reflecting
less activated eosinophils in patients with AR com-
pared to patients with asthma and patients with both
conditions.
The present study shows that the three groups of
patients had reduced antioxidant capacity as shown
by decreased TAC in comparison with the control. In
addition, there was a highly significant difference in
serum TAC between the three groups. Others51-53
have reported the reduction in serum TAC in asth-
matic and AR patients. The decreased TAC is related
to attack and severity51,53 and the decrease in TAC
may result from different mechanisms in patients
with asthma and AR as a consequence of increased
oxidative stress. Accordingly as a result of the imbal-
ance between oxidative and antioxidant materials, re-
duction in TAC was achieved. Therefore, it seems
that measurement of TAC in serum could be a simple
and useful tool in the evaluation of AR and asthma at-
tack and severity. The supplementary administration
of antioxidants in the future needs further study and
clarification.
The present study indicated that lipid peroxidation
as measured by serum MDA level, was increased in
patients with AR alone, asthma alone or with both
conditions. Furthermore, the increased mean serum
levels were significantly different between the three
groups of patients. However, the difference in mean
serum MDA values between patients with AR alone
and asthma alone had marginal significance (P <
0.05). Previous reports indicated that plasma and se-
rum MDA levels were higher in patients with
asthma52,54-56 and AR53 as compared to controls.
The findings from this study suggest that in pa-
tients with both asthma and AR, there is local and
systemic inflammation, which is more severe when
present together. These findings highlight the possi-
bility that comorbid AR may lead to more difficult to
control asthma and worsened asthma outcome. The
increased serum levels of MDA and decreased TAC
observed in the present study indicate increased oxi-
dative stress in AR and asthmatic patients.
In the present study the oxidantantioxidant bal-
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ance seems to be disturbed in asthma and AR as com-
pared to controls. The imbalance between oxidant
and antioxidant presented as oxidation index. It was
1.74 times higher in AR, asthma and both disease
groups than that in controls. That means the oxida-
tive stress is a prominent event in asthma and AR and
its extent is more when the two conditions are pre-
sent in the same patient. In this respect, the imbal-
ance was higher in patients with both conditions as
compared to those with AR alone (3 times) or asthma
alone (2 times). This finding suggests that oxidative
stress plays an important role in the pathogenesis of
AR and asthma and there is a positive correlation be-
tween oxidative stress and disease severity. The in-
flammatory process was the likely source for this im-
balance. Both airway and intravascular inflammatory
cells contribute to elevated oxidative stress in AR and
asthma and this explains why oxidation indexes were
high in individuals with comorbid AR in asthmatic pa-
tients.
Not all patients with asthma have rhinitis; however,
not all patients with rhinitis have asthma. Genetic dif-
ferences contribute to this discrepancy.57 Possible
mechanisms for the influence of AR on lower airways
include disturbance of the beneficial role of nasal mu-
cosa in conditioning the air entering the respiratory
tree, neural interaction between upper and lower air-
ways; irritant effects on nasal secretions directly en-
tering the lower airways; and systemic propagation of
nasal inflammation to the bronchial mucosa (or vice
versa) via effects of mediators and inflammatory cells
on bone marrow-systemic cross-talk.38,39,58
In conclusion, this study provided evidence that al-
lergic rhinitis and asthma are strongly associated
with each other and the treatment approach should
consider the entire airway rather than only a part.
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